Aditxt Goodwill and Intangible Assets 2020-2025 | ADTX

Aditxt goodwill and intangible assets from 2020 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Aditxt Goodwill and Intangible Assets 2020-2025 | ADTX

Aditxt goodwill and intangible assets from 2020 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$80.2B
Zoetis (ZTS)$68.3B
Daiichi Sankyo, - (DSNKY)$47.1B
Takeda Pharmaceutical (TAK)$46.9B
BeOne Medicines - (ONC)$32.3B
Sandoz Group AG (SDZNY)$26.4B
Summit Therapeutics (SMMT)$20.8B
Merck (MKKGY)$17.3B
Shionogi (SGIOY)$14.5B
United Therapeutics (UTHR)$13.8B
Neurocrine Biosciences (NBIX)$13.2B
Orion OYJ (ORINY)$11.7B
IPSEN (IPSEY)$10.9B
Stevanato Group S.p.A (STVN)$7.7B
Corcept Therapeutics (CORT)$7.3B
Madrigal Pharmaceuticals (MDGL)$6.8B
Grifols, S.A (GRFS)$6.8B
Ionis Pharmaceuticals (IONS)$6.7B
Hikma Pharmaceuticals Plc (HKMPF)$5.9B
Ono Pharmaceutical (OPHLF)$5.2B
Soleno Therapeutics (SLNO)$4.4B
Hypermarcas (HYPMY)$3.1B
Crinetics Pharmaceuticals (CRNX)$2.9B
NewAmsterdam Pharma (NAMS)$2.7B
Catalyst Pharmaceuticals (CPRX)$2.6B
Procaps Group, S.A (PROCF)$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.5B
Centessa Pharmaceuticals (CNTA)$2.1B
Ocular Therapeutix (OCUL)$1.9B
BioCryst Pharmaceuticals (BCRX)$1.8B